Bristol-Myers prevails over Gilead in Yescarta royalty row - Bloomberg Law
December 13, 2019 at 15:08 PM EST
Bristol-Myers Squibb Co won a patent infringement trial against Gilead Sciences Inc's unit Kite Pharma over cancer immunotherapy Yescarta, Bloomberg Law reported on Friday.
